Article
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predisposition.
Annals of surgical oncology - 1 Dec 2011
Bacolod Manny D, Barany Francis
Abstract excerpt
If properly translated to clinical use, our knowledge about biomarkers may lead to a more effective way of combating colorectal cancer (CRC). Biomarkers are biomolecular, genetic, or cytogenetic attributes indicative of the disease's progression, predisposition, prognosis, or therapeutic options. For CRC, these include chromosomal instability, mutations in KRAS and TP53, loss of 18q, and elevated level of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
